| Edward L Burkhalter, MD | |
|
1417 S. Cliff Ave., Ste. 300, Sioux Falls, SD 57105-1062 | |
| (605) 322-8630 | |
| (605) 322-8631 |
| Full Name | Edward L Burkhalter |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1417 S. Cliff Ave., Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396708046 | NPI | - | NPPES |
| 92411422906 | Other | MN | PRIMEWEST |
| 45358 | Other | SD | SANFORD HEALTH PLAN |
| 3185967 | Medicaid | IA | |
| 57105B031 | Other | SD | WPS TRICARE |
| 186P6BU | Other | MN | CC SYSTEMS/ BLUE PLUS |
| 370624200 | Other | SD | DEPT OF LABOR |
| 4994677 | Other | SD | BLUE CROSS |
| 6005120 | Medicaid | SD | |
| 186P6BU | Other | MN | BLUE CROSS |
| 2391537 | Other | SD | ARAZ/ AMERICA'S PPO |
| 2900425 | Other | SD | MEDICA |
| 5516 | Other | SD | DAKOTACARE |
| 789434100 | Medicaid | MN | |
| HP55732 | Other | SD | HEALTHPARTNERS |
| 46022474338 | Medicaid | NE | |
| 769171045255 | Other | SD | PREFERRED ONE |
| 11660 | Other | SD | MIDLANDS CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 5516 (South Dakota) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 9339 (South Dakota) | Primary |
| Entity Name | Southeast Missouri Hospital Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558311522 PECOS PAC ID: 9133024334 Enrollment ID: O20031201000775 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward L Burkhalter, MD 2400 S. Minnesota Ave., Ste. 100, Sioux Falls, SD 57105-3762 Ph: (605) 322-7510 | Edward L Burkhalter, MD 1417 S. Cliff Ave., Ste. 300, Sioux Falls, SD 57105-1062 Ph: (605) 322-8630 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
› Verified 5 days ago
Jaroslaw Mateuszczyk, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-328-8188 | |
Aaron Burkhardt, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6100 S Louise Ave Ste 1120, Sioux Falls, SD 57108 Phone: 605-504-1700 | |
Curtis Blake Rexroth, Gastroenterology Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-8000 | |
Vinod Parameswaran, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1000 E. 23rd St., Ste. 200, Sioux Falls, SD 57105 Phone: 605-322-3035 Fax: 605-322-3036 | |
Lloyd E Solberg, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1301 W 18th St, Sioux Falls, SD 57105 Phone: 605-312-2200 | |
Ismail Omran, Gastroenterology Medicare: Medicare Enrolled Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-238-8100 | |
Francine Vanessa Arneson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 911 E. 20th St., Ste. 509, Sioux Falls, SD 57105 Phone: 605-322-8993 |